ArticleJournal of medical virology2023

Anti-SARS-CoV-2 activity of targeted kinase inhibitors: Repurposing clinically available drugs for COVID-19 therapy.

RuthMabel Boytz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.